Issue Information
15 June 2022
Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature
Myung‐Ho Kim, Mi‐Young Kim, Shadi Salloum, Tongqi Qian, Lai Ping Wong, Min Xu, Yoojin Lee, Stuti G. Shroff, Ruslan I. Sadreyev, Kathleen E. Corey, Thomas F. Baumert, Yujin Hoshida, Raymond T. Chung – 15 June 2022 – Lipophilic but not hydrophilic statins have been shown to be associated with reduced risk for hepatocellular carcinoma (HCC) in patients with chronic viral hepatitis. We investigated differential actions of lipophilic and hydrophilic statins and their ability to modulate a clinical prognostic liver signature (PLS) predicting HCC risk in patients with liver disease.
Issue Information
15 June 2022
Comparison of infection‐induced and vaccine‐induced immunity against COVID‐19 in patients with cirrhosis
Binu V. John, Akash Doshi, Raphaella D. Ferreira, Tamar H. Taddei, David E. Kaplan, Seth A. Spector, Yangyang Deng, Dustin Bastaich, Bassam Dahman – 15 June 2022
Issue Information
15 June 2022
Alpha‐kinase 1 (ALPK1) agonist DF‐006 demonstrates potent efficacy in mouse and primary human hepatocyte (PHH) models of hepatitis B
Cong Xu, Jieqing Fan, Danyang Liu, Aimaier Tuerdi, Juanjuan Chen, Yuning Wei, Yanfang Pan, Huaixin Dang, Xiong Wei, Ashraf Siddig Yousif, Jeysen Yogaratnam, Qiong Zhou, Henri Lichenstein, Tian Xu – 13 June 2022
Reply
Hiroki Murai, Takahiro Kodama, Tetsuo Takehara – 13 June 2022